valuetrade

[valuetrade @Scopes89]

$QNGY let’s be honest this would be way worse if this were another offering. The share structure is the same. Loading this up tomorrow.

[valuetrade @Scopes89]

$QNGY this will trade beautifully on the OTC.

[valuetrade @Scopes89]

$FWBI I have a feeling this will be a 200%+ week. Hype + bottom + undervalued + 565k short at an avg of 10% below current SP. Piece of cake.

[valuetrade @Scopes89]

@buttbuddyboy I wouldn’t get MULN until sub .20. FWBI hands down

[valuetrade @Scopes89]

$FWBI 🚀🚀🚀🚀🚀 crazy worldwide hype! The word is out, shorts trapped 😛😛😛😛

[valuetrade @Scopes89]

$FWBI put up that fake wall so I can get in later!

[valuetrade @Scopes89]

$Fwbi keep it below 1.50 and I buy 60k at 7am!

[valuetrade @Scopes89]

$FWBI has taken over the world, the darling bio stock had a hoy of $90 pre r/s and easily valued in the $18-$20 area. This can be a multi week run, Unbelievable opportunity.

[valuetrade @Scopes89]

$FWBI buying 50-60k tomorrow if below 1.50 by 7am.

[valuetrade @Scopes89]

$FWBI loading this the F up tomorrow

[valuetrade @Scopes89]

$NERV $VTGN $SAVA $AMC $GME

[Gambler @MR_Gamblers1]

$FWBI Imagine the burden of having to take a pill every 15 minutes of life. How would you be able to have a job, drive a car, do an activity for fun? There is no current treatment for CF that comes close to Adrulipase. This is why this will be a billion dollar drug.

[valuetrade @Scopes89]

$FWBI banging my hands on the table for this one. No better value on any Nasdaq play this year.

[valuetrade @Scopes89]

Everyone seems to be on $FWBI right now, and this is the bottom.

How many times do you see a runner that’s not frontloaded. This never happens.
$IMPP $ILUS $VTNG $APE $GME

[valuetrade @Scopes89]

$FWBI Is an excellent entry and I believe is the best value on Nasdaq.
Adrulipase is the most advanced asset in the First Wave pipeline. With the anticipation of phase to starting we expect a run to $8-$12 as a conservative estimate.

[valuetrade @Scopes89]

$FWBI phase 2 for (IND) commencement begins before EOY.

[Entero Therapeutics (Nasdaq: ENTO) @enterothera]

@firstwavebio presented research demonstrating key advantages of its improved #adrulipase drug delivery formulation at AAPS 2022 PharmSci 360. View our poster at https://t.co/WkWttIV6C2
#Biotechnology #Gastrointestinal #PosterPresentation #Pharmaceutical

[valuetrade @Scopes89]

$FWBI is now the most undervalued play

$APE $NILE $ILUS $HUSA $IMPP

[valuetrade @Scopes89]

$FWBI on short squeeze alert.
Low float undervalued,running into catalysts

[valuetrade @Scopes89]

$BWV Microcap bios are making a comeback. This one you can get the full ride from the bottom.

[valuetrade @Scopes89]

$APE $RMED $MEGL $HKD

Calling $BWV as the bottom play runner of the year now. Way undervalued as this has a universal flu vaccine in the pipeline as long as many others. This hit $91 in February and now 1.35.

Should see $16-$20 this year as soon as clinical trials commence.

[valuetrade @Scopes89]

$BWV 60k deep now. I’m loving this bad boy.